Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Risperidone 500microgram tablets
040201030AAAKAK
|
Risperidone (Systemic) | Risperidone | Central Nervous System | 91,293 |
|
Risperidone 1mg tablets
040201030AAAAAA
|
Risperidone (Systemic) | Risperidone | Central Nervous System | 85,641 |
|
Risperidone 2mg tablets
040201030AAABAB
|
Risperidone (Systemic) | Risperidone | Central Nervous System | 66,857 |
|
Risperidone 3mg tablets
040201030AAACAC
|
Risperidone (Systemic) | Risperidone | Central Nervous System | 36,679 |
|
Risperidone 4mg tablets
040201030AAADAD
|
Risperidone (Systemic) | Risperidone | Central Nervous System | 36,298 |
|
Risperidone 1mg/ml oral solution sugar free
040201030AAAEAE
|
Risperidone (Systemic) | Risperidone | Central Nervous System | 23,995 |
|
Risperidone 250microgram tablets
040201030AAATAT
|
Risperidone (Systemic) | Risperidone | Central Nervous System | 16,188 |
|
Risperidone 500microgram orodispersible tablets sugar free
040201030AAANAN
|
Risperidone (Systemic) | Risperidone | Central Nervous System | 4,569 |
|
Risperidone 6mg tablets
040201030AAAFAF
|
Risperidone (Systemic) | Risperidone | Central Nervous System | 3,352 |
|
Risperidone 1mg orodispersible tablets sugar free
040201030AAALAL
|
Risperidone (Systemic) | Risperidone | Central Nervous System | 1,985 |
|
Risperidone 2mg orodispersible tablets sugar free
040201030AAAMAM
|
Risperidone (Systemic) | Risperidone | Central Nervous System | 1,703 |
|
Risperidone 3mg orodispersible tablets sugar free
040201030AAAPAP
|
Risperidone (Systemic) | Risperidone | Central Nervous System | 885 |
|
Risperidone 4mg orodispersible tablets sugar free
040201030AAAQAQ
|
Risperidone (Systemic) | Risperidone | Central Nervous System | 867 |
|
Risperdal Consta 50mg inj vials
0402020AABBABAB
|
Risperdal Consta | Risperidone | Central Nervous System | 623 |
|
Risperidone 50mg inj vials
0402020AAAAABAB
|
Risperidone (Parenteral) | Risperidone | Central Nervous System | 559 |
|
Risperdal Consta 25mg inj vials
0402020AABBAAAA
|
Risperdal Consta | Risperidone | Central Nervous System | 503 |
|
Risperidone 25mg inj vials
0402020AAAAAAAA
|
Risperidone (Parenteral) | Risperidone | Central Nervous System | 467 |
|
Risperidone 37.5mg inj vials
0402020AAAAACAC
|
Risperidone (Parenteral) | Risperidone | Central Nervous System | 466 |
|
Risperdal Consta 37.5mg inj vials
0402020AABBACAC
|
Risperdal Consta | Risperidone | Central Nervous System | 373 |
|
Risperdal 500microgram tablets
040201030BBAGAK
|
Risperdal | Risperidone | Central Nervous System | 225 |
|
Risperdal 1mg tablets
040201030BBAAAA
|
Risperdal | Risperidone | Central Nervous System | 179 |
|
Risperdal 2mg tablets
040201030BBABAB
|
Risperdal | Risperidone | Central Nervous System | 163 |
|
Risperdal 1mg/ml oral solution
040201030BBAEAE
|
Risperdal | Risperidone | Central Nervous System | 82 |
|
Risperdal 3mg tablets
040201030BBACAC
|
Risperdal | Risperidone | Central Nervous System | 73 |
|
Risperdal 4mg tablets
040201030BBADAD
|
Risperdal | Risperidone | Central Nervous System | 72 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.